Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

ETR/RDC stock hub

ETR/RDC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/RDCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

888.5M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/RDC

In the news

Latest news · ETR/RDC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-8.1

P25 -6.7P50 8.5P75 17.2

ROIC-1.2

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/RDC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

EUR

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	2,163
Employees Change	336%
Employees Change Percent	18.39
Enterprise value	EUR 1.1B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	NL0012044747
Last refreshed	2026-05-10
Market cap	EUR 888.5M
Price	EUR 44.18
Price currency	EUR
Rev Per Employee	1,420,758.21x
Sector	Healthcare
Sic	5912
Symbol	etr/RDC
Website	https://www.redcare-pharmacy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.21%
EV Earnings	-30.12x
EV/EBITDA	74.11x
EV/FCF	-17.88x
EV/Sales	0.37x
FCF yield	-7.09%
P/B ratio	1.9x
P/S ratio	0.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.49%
EBITDA Margin	0.23%
Gross margin	21.93%
Gross Profit	EUR 673.8M
Gross Profit Growth	15.73%
Gross Profit Growth Q	6.4%
Gross Profit Growth3 Y	23.94%
Gross Profit Growth5 Y	22.68%
Net Income	EUR -37.4M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-1.47%
Profit Margin	-1.22%
Profit Per Employee	EUR -17,291
ROA	-0.86
Roa5y	-2.15
ROCE	-1.88
ROE	-8.07
Roe5y	-11.42
ROIC	-1.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-63.81%
Cagr3y	-21.64%
Cagr5y	-22.82%
EPS Growth Quarters	1
EPS Growth Years	1
FCF Growth Q	-59.76%
OCF Growth	-56.02%
OCF Growth Q	-38.86%
OCF Growth5 Y	-13.98%
Revenue Growth	21.58x
Revenue Growth Q	18.43x
Revenue Growth Quarters	18x
Revenue Growth Years	12x
Revenue Growth3 Y	34.2x
Revenue Growth5 Y	24.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 2.79
Assets	EUR 1.2B
Cash	EUR 135M
Current Assets	EUR 579.3M
Current Liabilities	EUR 375.1M
Debt	EUR 354.8M
Debt EBITDA	EUR 24.64
Debt Equity	EUR 0.76
Debt FCF	EUR -5.63
Equity	EUR 468.3M
Interest Coverage	-0.67
Liabilities	EUR 710.1M
Long Term Assets	EUR 599.1M
Long Term Liabilities	EUR 335M
Net Cash	EUR -219.8M
Net Cash By Market Cap	EUR -24.74
Net Debt EBITDA	EUR 30.53
Net Debt Equity	EUR 0.47
Tangible Book Value	EUR 60.3M
WACC	10.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.54
Inventory Turnover	12.75
Net Working Capital	EUR 92.2M
Quick ratio	0.78
Working Capital	EUR 204.2M
Working Capital Turnover	EUR 14.21

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-63.79%
200-day SMA	66.81
3Y total return	-51.89%
50-day SMA	43.82
50-day SMA vs 200-day SMA	50under200
5Y total return	-72.61%
All Time High	249
All Time High Change	-82.26%
All Time High Date	2021-02-16
All Time Low	24
All Time Low Change	84.08%
All Time Low Date	2016-12-09
ATR	2.87
Beta	1.45
Beta1y	2.91
Beta2y	1.62
Ch YTD	-32.14
High	46.98
High52	130.1
High52 Date	2025-05-22
High52ch	-66.04%
Low	42.4
Low52	30.2
Low52 Date	2026-03-30
Low52ch	46.29%
Ma50ch	0.81%
Price vs 200-day SMA	-33.88%
RSI	44.44
RSI Monthly	32.65
RSI Weekly	39.08
Sharpe ratio	-1.6x
Sortino ratio	-2
Tr YTD	-32.14
Tr1m	23.68%
Tr1w	-9.8%
Tr3m	-31.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -15.1M
Operating margin	-0.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,822,057%
Net Borrowing	64,300,000
Shares Insiders	13.67%
Shares Institutions	27.39%
Shares Out	20,111,554

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -66.8M
Average Volume	157,115.9x
CAPEX	EUR -79.7M
Ch1m	23.68
Ch1w	-9.8
Ch1y	-63.79
Ch3m	-31.66
Ch3y	-51.89
Ch5y	-72.61
Ch6m	-27.75
Change	-4%
Change From Open	-3.45
Close	46.02
Days Gap	-0.56
Depreciation Amortization	22,300,000
Dollar Volume	7,820,390.2
Earnings Date	2026-05-06
EBIT	EUR -15.1M
EBITDA	EUR 7.2M
F Score	3
FCF	EUR -63M
FCF EV Yield	-5.59x
FCF Per Share	EUR -3.13
Financing CF	50,600,000
Fiscal Year End	December
Founded	2,001
Income Tax	EUR -6.5M
Investing CF	-78,200,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	59.95
Ma150ch	-26.3%
Ma20	47.28
Ma20ch	-6.56%
Net CF	-11,100,000
Next Earnings Date	2026-07-29
Open	45.76
P OCF Ratio	53.21
Position In Range	38.86
Ppne	198,600,000
Price Date	2026-05-08
Price EBITDA	EUR 123
Ptbv Ratio	14.74
Relative Volume	1.18x
Revenue	3,073,100,000x
SBC By Revenue	0.12x
Share Based Comp	3,800,000
Tax By Revenue	-0.21x
Tr6m	-27.75%
Volume	177,012

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/RDC pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/RDC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/RDC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.4%

Share of float held by funds and institutions

Insider ownership

+13.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/RDC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.4

Neutral momentum band

Price vs 200-day MA

-33.9%

50/200-day relationship not available

Beta (5Y)

1.45

More volatile than the market

Sharpe ratio

-1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/RDC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/RDC stock rating?

etr/RDC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/RDC analysis?

The full report lives at /stocks/etr/RDC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/RDC?

The latest report frames etr/RDC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/RDC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.